






























atrial	 fibrillation	 depending	 on	 different	 approaches	 to	 treatment.	 The	 study	
involved	254	patients	with	paroxysmal	and	persistent	forms	of	atrial	fibrillation	
and	42	practically	healthy	persons.	The	main	features	of	anamnesis,	presence	of	
comorbidities,	 aggravating	 risk	 factors	were	 studied	 as	well	 as	 a	 survey	using	
“AFEQT	 Questionnaire”	 was	 conducted.	 When	 studying	 the	 anamnesis	 it	 was	
revealed	that	patients	treated	by	medications	only	(the	first	experimental	group)	
had	 arterial	 hypertension	 as	 a	 main	 presumable	 cause	 of	 atrial	 fibrillation	
(92.4%);	in	one	third	of	cases	different	forms	of	coronary	artery	disease	and	heart	
failure	were	diagnosed	(38.6%	and	33.3%,	respectively).	In	the	fourth	group	(after	
left	 ventricular	 revascularization)	 a	 prevailing	 cause	 of	 atrial	 fibrillation	 was	
coronary	heart	disease	 (100%).	 In	the	second	group	 (after	cardioversion)	as	well	
as	 in	the	third	group	 (after	ablation)	the	 largest	proportion	of	patients	was	also	
diagnosed	with	arterial	hypertension	–	62.0%	and	40.9%,	respectively.	The	mean	
total	AFEQT	 score	among	 the	 control	group	was	82.3±3.1	points.	Patients	of	 the	
first	 group	 scored	 the	 minimum	 value	 among	 interviewed	 patients	 -53.4±4.6	 -	
that	 was	 significantly	 less	 compared	 to	 the	 control	 group,	 р<0.05.	 The	 total	
average	value	of	 the	 third	group	was	significantly	higher	 than	 that	 in	 the	 first	
group,	69.3±4.6	points	against	53.4±4.6	points,	respectively,	р<0.05.	
	 Thus,	 it	 was	 found	 that	 the	 lowest	 life	 quality	 is	 typical	 for	 patients	
treated	with	medications	only.	The	patients	after	ablation	have	the	highest	 life	
















life	 in	 these	 patients	 would	 allow	 us	 to	 detect	 and	 correct	 the	 abnormalities	 timely.	 Although	
currently	 there	 is	 a	 number	 of	 questionnaires	 and	 scales	 a	 unique	 common	 approach	 to	
assessment	of	 the	 entire	 spectrum	of	patients’	 life,	their	physical	performance	and	mental	well-
being	has	not	developed	yet	[4,	10,	13,	14].	Traditionally,	the	major	efforts	of	clinicians	were	aimed	
at	reducing	morbidity	and	mortality	rates	among	patients	with	AF	[8,	12].	However,	several	studies	
demonstrate	 the	 importance	of	 life	quality	 itself.	And	 the	effectiveness	of	many	medicaments	 is	










50	 persons	 after	 LV	 revascularization.	 Patients	 were	 selected	 in	 accordance	 with	 the	 inclusion	
criteria:	patient’s	consent	and	compliance,	availability	of	clinical	and	 instrumental	criteria	for	AF	
according	to	the	protocol	of	medical	care	in	the	specialty	“Cardiology”.	The	exclusion	criteria	were	






offered	 to	 fill	 in	 by	 all	 patients	 before	 history	 taking	 and	 assessment	 of	 patients’	 condition.	 It	
consists	of	20	 items.	The	responses	are	scored	 from	1	 to	7	Likert	scale,	where	questions	1-18	are	
formed	as	value	judgments	(1=	“Not	at	all…”	to	7	=	“Extremely...”).	Questions	19-	21	relate	to	patients’	









treatment	 were	 not	 included	 in	 the	 overall	 AFEQT	 score	 and	 were	 calculated	 and	 scored	
independently.	 Overall	 scores	 ranged	 from	 0	 to	 100.	 A	 score	 of	 0	 corresponded	 to	 complete	
disability,	while	a	 score	of	100	corresponded	 to	 the	 lack	of	deterioration	of	quality	of	 life.	When	







The	 scale	 “EHRA”	was	used	 to	 evaluate	 the	 severity	 of	 symptoms.	 Class	 I	 indicated	 the	
absence	of	symptoms;	Class	II	pointed	to	the	presence	of	mild	symptoms	not	affecting	normal	daily	
activities;	Class	 III	 indicated	 the	 presence	 of	 severe	 symptoms	 affecting	normal	 daily	 activities;	
Class	IV	pointed	to	the	presence	of	disabling	symptoms	precluding	normal	daily	activities.		
The	significance	of	difference	between	dependent	and	independent	variants	was	evaluated	









groups,	respectively.	 In	 the	 third	research	group	 (after	ablation)	 there	were	4.6%	of	such	cases.	 It	
should	 be	 noted	 that	 the	 most	 number	 of	 cases	 with	 absence	 of	 symptoms	 disabling	 the	 daily	
activities	was	detected	 in	the	third	experimental	group,	54.6%.	At	the	same	time,	 in	the	 first	and	
second	research	groups	the	proportion	of	such	patients	was	22.0%	and	20.0%,	respectively.	Thus,	






When	 studying	 the	 anamnesis	 we	 revealed	 the	 following	 patterns.	 The	 main	 probable	
factors	related	to	the	development	and	recurrence	of	arrhythmia	in	each	research	group	included	
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group	had	arterial	hypertension	as	a	main	presumable	 cause	of	atrial	 fibrillation	 (92.4%);	 in	one	
third	of	cases	different	 forms	of	coronary	artery	disease	and	heart	 failure	were	diagnosed	 (38.6%	
and	33.3%,	respectively).	 In	 the	 fourth	group	a	prevailing	cause	of	atrial	 fibrillation	was	coronary	
heart	disease	 (100%).	 In	the	second	group	 (after	cardioversion)	as	well	as	 in	the	third	group	 (after	
ablation)	the	 largest	proportion	of	patients	was	also	diagnosed	with	arterial	hypertension	–	62.0%	
and	40.9%,	respectively.	According	to	the	Framingham	heart	study	the	most	frequent	causes	of	AF	






When	 analyzing	 complications	 we	 stated	 that	 cerebral	 blood	 flow	 disorders	 were	 most	 often	
diagnosed	in	the	first	group	(19.7%)	(patients	treated	by	medications	only).	Among	patients	with	AF	
who	underwent	LV	revascularization	(the	fourth	group)	more	than	10	%	had	previous	stroke	or	TIA.	
It	should	be	noted	 that	among	 the	second	 research	group	only	4.0%	of	such	cases	were	detected	
and	 among	 the	 third	 one	 there	 was	 no	 patients	 with	 such	 a	 disease.	 Bleeding	 was	 most	 often	




of	 the	 first	group,	2.0%	and	4.6%	of	patients	of	 the	 second	and	 third	groups,	 respectively.	 It	was	
diagnosed	in	6.0%	of	cases	among	persons	of	the	fourth	group.	
When	analyzing	 the	 impact	of	stress	 factors	 (self-assessment	 from	“0”	to	“10”	points),	we	
found	that	the	significant	impact	of	stress	(“5-7”	points)	was	indicated	by	56.8%	of	patients	of	the	
first	group,	58.0%	of	patients	of	the	second	group	and	50.0%	of	patients	of	the	fourth	groups.	About	
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6.0%	 of	 patients	 of	 the	 fourth	 group.	 Severe	 stress	 (“7-10”	 points)	 was	 reported	 by	 4.6%	 of	
respondents	of	 the	 third	group,	6.0%	of	patients	of	 the	 fourth	group,	8.3%	of	patients	of	 the	 first	
group	and	14.0%	of	patients	of	the	second	group.	There	were	no	 individuals	with	severe	stress	 in	
the	control	group.	
While	 analyzing	 weekly	 physical	 activity,	 which	 was	 rated	 as	 the	 number	 of	 days	 of	
moderate	physical	activity	a	week	 it	was	 revealed	 the	 following.	 It	 should	be	noted	 that	among	
patients	of	almost	all	groups	persons	with	 low	physical	activity	 (1-2	active	days/week)	prevailed.	
Thus,	 there	were	 65.9%	 and	 70.0%	 of	 patients	with	 such	 activity	 in	 the	 first	 and	 fourth	 groups,	
respectively.	More	than	half	of	these	persons	were	present	in	the	second	group	(52.0%).	The	largest	
number	of	patients	with	moderate	weekly	activity	 (active	3-4	days/week)	was	 in	 the	 third	group	
(after	ablation).	
Some	of	these	trends	were	also	confirmed	while	assessing	the	life	quality	(Table	1).	First	of	























	 	 	 	 	 	
Overall	score	 82.3±3.1	 53.4±4.6*	 59.6±4.2*	 69.3±4.6*¶	 56.3±3.9*	













Daily	activities	 89.3±2.9	 51.3±3.6*	 54.2±3.4*	 63.3±3.4*¶	 57.3±3.3*	
Treatment	
satisfaction	



















63.3±3.4	points.	 In	 the	 first	 group	 and	 the	 second	 group	 these	 value	 were	 51.3±3.6	and	54.2±3.4	
points,	 respectively.	 The	 difference	 in	 the	 data	 between	 the	 first	 and	 the	 third	 groups	 was	
statistically	significant,	р<0.05.		
The	 values	 for	 subscale	 “Treatment	 satisfaction”	were	also	characteristic.	Patients	 of	 the	
first	group	were	 the	 least	satisfied	with	 treatment.	The	maximum	score	 for	 this	subscale	 in	 this	
group	 ranged	 within	 49.8±4.0	points.	Patients	of	 the	second	and	 fourth	 groups	 were	 moderately	
satisfied	with	the	progress	and	results	of	treatment.	Their	values	were	55.3±3.0	and	61.2±4.1	points,	
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